Topic: healthcare

Analysts recommend buying dividend stocks like Abbott Laboratories (ABT) and Accenture (ACN) for portfolio income in 2026

06/26/2026, 11:37 AM investing recommendation Analysts: analysts healthcare finance

In a high-priced stock market, investors are increasingly looking for undervalued dividend stocks that provide income while they wait for potential price appreciation. This strategy is particularly relevant given the current market volatility and inflation concerns.

Estrogen Patch Shortage Persists Amid Rising Demand for Menopause Treatments

06/26/2026, 04:37 AM business growth healthcare

The rising demand for estrogen patches, driven by increased awareness and a recent FDA policy change, has led to significant shortages that may persist for up to two years, impacting women's access to menopause treatments.

Analysts Bank of America and TD Cowen Highlight Growth Potential in Small Cap Stocks Freshpet (FRPT) and Omnicell (OMCL)

06/25/2026, 01:35 PM investing review Analysts: analysts, Bank of America, TD Cowen healthcare consumer

Small cap stocks are experiencing their strongest performance in over three decades, with analysts from Bank of America and TD Cowen recommending specific companies for investors to consider as they capitalize on this trend.

Chan Zuckerberg Initiative’s Biohub to Launch New Funding Round for Rare Diseases

06/25/2026, 09:36 AM business announcement healthcare

Biohub, supported by the Chan Zuckerberg Initiative, is launching a new funding round for rare disease research, emphasizing the role of patient-led organizations in scientific progress. This initiative is part of a broader strategy to leverage AI in developing treatments for rare diseases.

IQVIA’s AI Platform Enhances Competitive Advantage in Drug Development Amid Growing Demand

06/24/2026, 11:36 AM investing growth healthcare

IQVIA is poised for significant growth as it leverages its extensive healthcare data and new AI capabilities, despite currently being undervalued in the market. The company's recent guidance increase and record backlog highlight its strong position in the drug development sector.

UPS Invests $48 Million in Temperature-Controlled Facilities to Enhance Healthcare Logistics

06/22/2026, 06:37 AM business announcement healthcare

United Parcel Service's $48 million investment in temperature-controlled facilities highlights its strategic focus on the growing healthcare logistics sector, which is essential for transporting sensitive medications safely.

Analysts expect Natera (NTRA) stock to break out as momentum improves

06/17/2026, 08:37 AM investing forecast Analysts: analysts healthcare

Natera Inc. (NTRA) is showing signs of a potential breakout in its stock price, which could lead to significant gains for investors if it surpasses key resistance levels. The company's strong performance relative to the healthcare sector further supports this bullish outlook.

JPMorgan Analysts Highlight Reopening Biotech IPO Market Amid Continued Big Pharma M&A Activity

06/15/2026, 10:36 PM business review Analysts: analysts, JPMorgan biotech healthcare

The biotech sector is experiencing a resurgence in public market activity, but many leading companies may prefer acquisition by larger pharmaceutical firms over pursuing initial public offerings (IPOs). This trend reflects a selective investment climate and a strategic shift in how biotech firms approach growth and funding.

Centene (CNC) Announces Voluntary Separation Program Amid Cost-Cutting Measures

06/15/2026, 01:37 PM business downsizing healthcare

Centene is offering buyouts to some employees as part of its strategy to manage rising medical costs and declining membership, which could signal further workforce reductions if targets are not met. This move reflects broader challenges in the healthcare sector, particularly for Medicaid providers.

Drugmakers Compete to Innovate in Obesity Treatment Market with New GLP-1 Pills and Alternative Therapies

06/13/2026, 05:36 AM business review healthcare

The race among drugmakers to develop innovative obesity treatments is intensifying, with Eli Lilly and Novo Nordisk leading the market while new entrants explore alternative therapies. This competition is crucial as it could reshape the landscape of weight-loss medications and impact pricing and accessibility for patients.